We observed that when the GSDME was depleted in the tumors, ORFV treatment was not able to recruit enough tumor-infiltrating CD8+, antigen-specific CD8+, and GzmB+CD8+ T cells, as compared to that in WT tumors (Fig. 4i, j and Supplementary Fig. 11). The gene discussed is GZMB; the disease is neoplasm.